Optical imaging to map blood-brain barrier leakage

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Jaffer, Hayder ^a   Adjei, Isaac M ^a   Labhasetwar, Vinod ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL; BLOOD BRAIN BARRIER; BRAIN; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC USE; DISEASE MODEL; DRUG EFFECTS; FLUORESCENCE IMAGING; MALE; METABOLISM; PATHOLOGY; PERMEABILITY; PROCEDURES; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; COLORING AGENTS; DISEASE MODELS, ANIMAL; MALE; OPTICAL IMAGING; PERMEABILITY; RATS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84887342017     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03117     Document Type: Article

References (32)

1. Rubin, L. L. &Staddon, J. M. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22, 11-28 (1999). (Pubitemid 29144879)
2. Kroll, R. A. &Neuwelt, E. A. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42, 1083-1099; discussion 1099-1100 (1998).
3. Manda, V. K., Mittapalli, R. K., Bohn, K. A., Adkins, C. E. &Lockman, P. R. Nicotine and cotinine increases the brain penetration of saquinavir in rat. J. Neurochem. 115, 1495-1507 (2010).
4. Blanchette, M. &Fortin, D. Blood-brain barrier disruption in the treatment of brain tumors. Methods Mol. Biol. 686, 447-463 (2011).
5. Qin, Y. et al. Comparison of four different peptides to enhance accumulation of liposomes into the brain. J. Drug Target. 20, 235-245 (2012).
6. Konofagou, E. E. et al. Ultrasound-induced blood-brain barrier opening. Curr. Pharm. Biotechnol. 13, 1332-1345 (2012).
7. Johansen, C. K.,Welker, K. M., Lindell, E. P. &Petty, G. W. Cerebral corticospinal tract injury resulting from high-voltage electrical shock. Am. J. Neuroradiol. 29, 1142-1143 (2008). (Pubitemid 351954883)
8. Risling, M. &Davidsson, J. Experimental animal models for studies on the mechanisms of blast-induced neurotrauma. Front. Neurol. 3, 30 (2012).
9. Ruda, R., Trevisan, E. &Soffietti, R. Epilepsy and brain tumors. Curr. Opin. Oncol. 22, 611-620 (2010).
10. McDannold, N., Vykhodtseva, N. &Hynynen, K. Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med. Biol. 34, 834-840 (2008). (Pubitemid 351608039)
11. Ichikawa, H. &Itoh, K. Blood-arachnoid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging. Brain Res. 1390, 142-149 (2011).
12. Huppert, J. et al. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J. 24, 1023-1034 (2010).
13. Ladewig, G. et al. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study. Exp. Neurol. 220, 207-211 (2009).
14. Kim, J. E., Ryu, H. J., Choi, S. Y. &Kang, T. C. Tumor necrosis factor-alphamediated threonine 435 phosphorylation of p65 nuclear factor-kappaB subunit in endothelial cells induces vasogenic edema and neutrophil infiltration in the rat piriform cortex following status epilepticus. J. Neuroinflammation. 9, 6 (2012).
15. Gartshore, G., Patterson, J. &Macrae, I. M. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp. Neurol. 147, 353-360 (1997). (Pubitemid 27497297)
16. Latour, L. L., Kang, D. W., Ezzeddine, M. A., Chalela, J. A. &Warach, S. Early blood-brain barrier disruption in human focal brain ischemia. Ann. Neurol. 56, 468-477 (2004). (Pubitemid 39319336)
17. Ballabh, P., Braun, A. &Nedergaard, M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1-13 (2004). (Pubitemid 38569790)
18. Caplan, L. R. Tissue Plasminogen Activator for Acute Ischemic Stroke. New Engl. J. Med. 333, 1581-1588 (1995).
19. Alexandrov, A. V. &Grotta, J. C. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 59, 862-867 (2002).
20. Qureshi, A. I. et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. Am. J. Neuroradiol. 25, 322-328 (2004). (Pubitemid 38235318)
21. Gilgun-Sherki, Y., Melamed, E. &Offen, D. Oxidative stress inducedneurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40, 959-975 (2001). (Pubitemid 32530602)
22. Bahmani, P. et al. Visualization of cell death in mice with focal cerebral ischemia using fluorescent annexin A5, propidium iodide, and TUNEL staining. J. Cereb. Blood Flow Metab. 31, 1311-1320 (2011).
23. Wunder, A., Schoknecht, K., Stanimirovic, D. B., Prager, O. &Chassidim, Y. Imaging blood-brain barrier dysfunction in animal disease models. Epilepsia 53 Suppl 6, 14-21 (2012).
24. Tofts, P. S. &Kermode, A. G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn. Reson. Med. 17, 357-367 (1991).
25. Suidan, G. L., McDole, J. R., Chen, Y., Pirko, I. &Johnson, A. J. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One 3, e3037 (2008).
26. Provenzale, J. M., Mukundan, S. &Dewhirst, M. The role of blood-brain barrier permeability in brain tumor imaging and therapeutics. Am. J. Roentgenol. 185, 763-767 (2005).
27. Klohs, J. et al. Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice. J. Neurosci. Methods 180, 126-132 (2009).
28. Liu, J., Jin, X., Liu, K. J. &Liu,W. Matrix metalloproteinase-2- mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J. Neurosci. 32, 3044-3057 (2012).
29. D'Aversa, T. G., Eugenin, E. A., Lopez, L. &Berman, J. W. Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis. Neuropathol. Appl. Neurobiol. 39, 270-283 (2013).
30. Wang, Z. et al. Potential contribution of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. J. Mol. Neurosci. 48, 273-280 (2012).
31. Zhang, Z. et al. A new rat model of thrombotic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17, 123-135 (1997). (Pubitemid 27085835)
32. Li, Y., Chen, J., Wang, L., Lu, M. &Chopp, M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56, 1666-1672 (2001). (Pubitemid 32574564)